Skip to main content Skip to section navigation Skip to footer
IR-Med, Inc.
  • How it Works
  • Indications
    • Pressure Injury
    • Pediatric Ear Infections
    • Drug-Level Monitoring
    • Cinical Research
  • Investors
  • About Us
    • Overview
    • Our Team
  • PressureSafe
  • Contact us
Menu
  • How it Works
  • Indications
    • Pressure Injury
    • Pediatric Ear Infections
    • Drug-Level Monitoring
    • Cinical Research
  • Investors
  • About Us
    • Overview
    • Our Team
  • PressureSafe
  • Contact us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • Advisory Board
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Presentations
  • Email Alerts
Mar 14, 2023 9:00 AM EDT

IR-Med to present at National Pressure Injury Advisory Panel 2023

Feb 14, 2023 9:15 AM EST

IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY

Feb 08, 2023 1:26 PM EST

IR-Med Gains Momentum in 2022

Nov 16, 2022 9:32 AM EST

IR-Med Announces Dr. David Dalton as Advisory Board member

Aug 30, 2022 9:15 AM EDT

IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device

Aug 12, 2022 8:34 AM EDT

IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries

Jun 23, 2022 9:15 AM EDT

IR-Med To Initiate Useability Study of its PressureSafe Device

May 10, 2022 4:17 PM EDT

IR-MED Names Moshe Gerber as New CEO

Apr 14, 2022 5:19 AM EDT

IR-Med Announces $3.2 Million Private Placement

Jan 25, 2022 11:41 AM EST

Following Its Recent Annual Updates: IR-Med Announces OTCQB Up-listing: “A Significant Achievement for the Company”

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed

MENU

  • Home
  • How it Works
  • Indications
  • Investors
  • About Us

Contact us

  • +972-4-6555054
  • contact@ir-medical.com
  • Z.H.R Industrial Zone, P.O. Box 143, 20 Yahalom St. Rosh Pinna, 1231400, ISRAEL

Social media

Twitter Linkedin

©2025 IR-Med, Inc., PressureSafe and Nobotics are trademarks of IR-MEd, Inc. All rights reserved.